FDA inspection
Contipro a.s.: FDA inspection ending Feb 15, 2024
FDA inspection 1271552 · Voluntary Action Indicated (VAI) · Dolni Dobrouc
Key facts
| Inspection ID | 1271552 |
|---|---|
| Firm | Contipro a.s. |
| FEI number | 3006440700 |
| Address | Dolni Dobrouc 401 |
| City | Dolni Dobrouc |
| Country | Czech Republic |
| Fiscal year | 2024 |
| Inspection end date | Feb 15, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data